We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimary Health Regulatory News (PHP)

Share Price Information for Primary Health (PHP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 93.35
Bid: 93.35
Ask: 93.50
Change: 1.70 (1.85%)
Spread: 0.15 (0.161%)
Open: 92.45
High: 93.55
Low: 91.90
Prev. Close: 91.65
PHP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - [Primary Healthcare Properties PLC]

27 Feb 2019 13:40



Form 8.3 - [Primary Healthcare Properties PLC]

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Rathbone Brothers Plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereePrimary Healthcare Properties PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure26/02/2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:  
InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:15,081,6121.92  
(2) Cash-settled derivatives:     
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:15,081,6121.92  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/sale Number of securitiesPrice per unit
12.5pPurchase 21,000120.35p
12.5pSale8,999120.30p
12.5pPurchase8,999120.30p

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/AN/A N/AN/AN/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
N/AN/AN/AN/AN/AN/AN/AN/A

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/AN/AN/AN/AN/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
N/AN/A N/AN/A

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

 27/02/2019
 Hannah Rimmer – Compliance Department
 0151 236 6666

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.


Date   Source Headline
19th Jun 20233:26 pmRNSDirector/PDMR Shareholding
19th Jun 20233:23 pmRNSDirector/PDMR Shareholding
14th Jun 20239:26 amRNSHolding(s) in Company
22nd May 20239:47 amRNSDirector/PDMR Shareholding
15th May 20239:18 amRNSDirector/PDMR Shareholding
26th Apr 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20233:58 pmRNSDirector/PDMR Shareholding
19th Apr 20233:23 pmRNSAGM Statement
19th Apr 20237:00 amRNSQ1 2023 Trading Update
11th Apr 20232:46 pmRNSDirector/PDMR Shareholding
11th Apr 20232:44 pmRNSDirector/PDMR Shareholding
6th Apr 202311:14 amRNSDirector’s & PDMR dealings
31st Mar 20239:20 amRNSHolding(s) in Company
23rd Mar 20237:00 amRNSNotice of Interim Dividend
15th Mar 20233:44 pmRNSDirector/PDMR Shareholding
15th Mar 20233:41 pmRNSDirector/PDMR Shareholding
15th Mar 202310:29 amRNSDirector/PDMR Shareholding
15th Mar 20238:39 amRNSAnnual Financial Report
14th Mar 202312:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:23 amRNSHolding(s) in Company
1st Mar 20239:43 amRNSDirector/PDMR Shareholding
1st Mar 20238:59 amRNSCompany Secretary Change
28th Feb 20234:17 pmRNSDirector/PDMR Shareholding
27th Feb 20234:56 pmRNSDirector/PDMR Shareholding
22nd Feb 20237:00 amRNSPreliminary Results
16th Feb 202311:38 amRNSHolding(s) in Company
8th Feb 202310:07 amRNSHolding(s) in Company
1st Feb 20239:40 amRNSHolding(s) in Company
23rd Jan 20237:00 amRNSAcquisition
16th Jan 20237:00 amRNSNotice of Preliminary Results
5th Jan 20237:00 amRNSDividend Declaration
19th Dec 202212:02 pmRNSDirector/PDMR Shareholding
15th Dec 20229:56 amEQSProactive Research Analyst Manos Halicioglu looks at Primary Health Properties
12th Dec 20227:00 amRNSSuccession Planning
6th Dec 20223:10 pmRNSHolding(s) in Company
30th Nov 202211:55 amRNSDirector/PDMR Shareholding
25th Nov 20222:19 pmRNSHolding(s) in Company
10th Nov 202210:30 amRNSDirector/PDMR Shareholding
7th Nov 202211:07 amRNSAppointment of joint broker
21st Oct 202212:01 pmRNSDirector/PDMR Shareholding
21st Oct 202212:00 pmRNSDirector/PDMR Shareholding
21st Oct 202212:00 pmRNSDirector/PDMR Shareholding
20th Oct 20224:39 pmRNSHolding(s) in Company
13th Oct 20225:00 pmRNSConvertible Bond Adjustment
6th Oct 20227:00 amRNSDividend Declaration
27th Sep 20227:00 amRNSValue Creation Award Win
14th Sep 20225:36 pmRNSDirector/PDMR Shareholding
14th Sep 20225:33 pmRNSDirector/PDMR Shareholding
12th Sep 202212:06 pmRNSDirector Declaration
22nd Aug 20222:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.